Skip to content
GLP-1 Scorecard
Menu
Graded #311

Aurelius Health Group

Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+, L-carnitine,…

Visit Aurelius Health GroupWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
$199/mo (microdose tier, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Line Aurelius Health Group up against its closest alternatives. Because Aurelius Health Group dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value54/100
Dose & formulation52/100
Clinical oversight76/100
Labs & monitoring63/100
Fulfillment61/100
Contract terms61/100

Strengths

  • Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
  • LegitScript Certified
  • Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
  • Unusually candid about the limited evidence base for microdosing

Where it loses points

  • The advertised $89 is a first-month new-patient rate; every month after it is $199
  • This is a 1 mg microdose programme and nothing else — no labelled therapeutic dose is sold, so it is not an alternative to a full-dose prescription
  • No state count is published, only 'most US states', confirmed at intake
  • The site's own comparison table calls 2.4 mg/week the tirzepatide 'standard full dose'; 2.4 mg is the semaglutide maintenance dose, and tirzepatide is labelled 2.5-15 mg/week
  • Compounded tirzepatide is not an FDA-approved finished product

Bottom line — Grade C

Best for: Shoppers who want transparent, care-inclusive compounded tirzepatide microdosing.

Ranked #311 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Aurelius Health Group — the realistic shortlist.

The 18 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Aurelius Health Group's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Aurelius Health Group's site. Not medical advice; see our disclosure.

← Back to the scorecard